Regarding all HCC, 56 of 70 (80.0%) patients had decreased levels of serum miR-223-3p <0.4, whereas 43 (61.4%) patients had elevated serum AFP at cut-off value of 20 ng/mL. This evidence concerns the gene AFP and hepatocellular carcinoma.